DE69415603T2 - Herstellungsverfahren für Amylaseinhibitoren - Google Patents

Herstellungsverfahren für Amylaseinhibitoren

Info

Publication number
DE69415603T2
DE69415603T2 DE69415603T DE69415603T DE69415603T2 DE 69415603 T2 DE69415603 T2 DE 69415603T2 DE 69415603 T DE69415603 T DE 69415603T DE 69415603 T DE69415603 T DE 69415603T DE 69415603 T2 DE69415603 T2 DE 69415603T2
Authority
DE
Germany
Prior art keywords
manufacturing process
amylase inhibitors
amylase
inhibitors
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69415603T
Other languages
English (en)
Other versions
DE69415603D1 (de
Inventor
Toshiyuki Miyazaki
Toshihisa Morimoto
Ryuji Murayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Pharma Inc
Original Assignee
Nagata Sangyo Co Ltd
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagata Sangyo Co Ltd, Nisshin Seifun Group Inc filed Critical Nagata Sangyo Co Ltd
Application granted granted Critical
Publication of DE69415603D1 publication Critical patent/DE69415603D1/de
Publication of DE69415603T2 publication Critical patent/DE69415603T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/16—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from waste water of starch-manufacturing plant or like wastes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/18—Vegetable proteins from wheat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69415603T 1993-08-06 1994-08-03 Herstellungsverfahren für Amylaseinhibitoren Expired - Fee Related DE69415603T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21350093A JP3499260B2 (ja) 1993-08-06 1993-08-06 アミラーゼ阻害物質の製造方法

Publications (2)

Publication Number Publication Date
DE69415603D1 DE69415603D1 (de) 1999-02-11
DE69415603T2 true DE69415603T2 (de) 1999-07-29

Family

ID=16640229

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69415603T Expired - Fee Related DE69415603T2 (de) 1993-08-06 1994-08-03 Herstellungsverfahren für Amylaseinhibitoren

Country Status (6)

Country Link
US (1) US5440019A (de)
EP (1) EP0637592B1 (de)
JP (1) JP3499260B2 (de)
AU (1) AU674760B2 (de)
CA (1) CA2129261C (de)
DE (1) DE69415603T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09194392A (ja) * 1996-01-18 1997-07-29 Nisshin Flour Milling Co Ltd アミラーゼ阻害物質
JP3999825B2 (ja) * 1996-01-18 2007-10-31 日清ファルマ株式会社 内臓脂肪蓄積抑制剤
JP2005213213A (ja) * 2004-01-30 2005-08-11 Fuji Oil Co Ltd 大豆トリプシンインヒビター濃縮物の製造法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2379929A (en) * 1942-06-22 1945-07-10 Tennessee Valley Authority Separating protein from waste material
US3950319A (en) * 1970-01-29 1976-04-13 Farbenfabriken Bayer Aktiengesellschaft Amylase inhibitor from wheat gluten using alcohol
US3898160A (en) * 1972-07-25 1975-08-05 Us Agriculture Recovering proteins from waste water
US4043990A (en) * 1974-03-20 1977-08-23 Stauffer Chemical Company Process for the recovery of whey protein having improved solution clarity using polyphosphates
US3944537A (en) * 1974-11-26 1976-03-16 The United States Of America As Represented By The Secretary Of Agriculture Preparation of alpha-amylase inhibitor
JPS57140727A (en) * 1981-02-10 1982-08-31 Nisshin Flour Milling Co Ltd Novel alpha-amylase inhibitor substance
JP2757404B2 (ja) * 1988-12-09 1998-05-25 日清製粉株式会社 小麦からα−アミラーゼインヒビター含有物質を取得する方法
JP2757405B2 (ja) * 1988-12-09 1998-05-25 日清製粉株式会社 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤
JP3195937B2 (ja) * 1992-04-22 2001-08-06 日清製粉株式会社 アミラーゼ阻害物質の取得方法

Also Published As

Publication number Publication date
JPH0748400A (ja) 1995-02-21
US5440019A (en) 1995-08-08
CA2129261A1 (en) 1995-02-07
AU6898794A (en) 1995-02-16
EP0637592A1 (de) 1995-02-08
DE69415603D1 (de) 1999-02-11
CA2129261C (en) 2004-07-27
EP0637592B1 (de) 1998-12-30
AU674760B2 (en) 1997-01-09
JP3499260B2 (ja) 2004-02-23

Similar Documents

Publication Publication Date Title
DE69333619D1 (de) Herstellungsverfahren für Halbleitersubstrate
DE59406621D1 (de) Herstellungsverfahren für vertikal kontaktierte halbleiterbauelemente
DE69522195D1 (de) Herstellungsverfahren für Halbleiteranordnungen
DE69429875T2 (de) Herstellungsverfahren für evakuierte verglasung
NO981938D0 (no) Proteaseinhibitorer
FI962315A (fi) Entsyymi-inhibiittorit
DE69409981T2 (de) Herstellverfahren für saugfähigen Artikel
DE69417368T2 (de) Reinigungsbehälter für Halbleitersubstrate
DE69527796D1 (de) Substratgläser für plasmaanzeige
DE69700481T2 (de) Herstellungsverfahren für elektronisches TFT-Bauelement
DE69615993T2 (de) Konstruktionsverfahren für ausbauarbeiten
DE69507362T2 (de) Optisches Kontrollverfahren für Gegenstände
DE69623788T2 (de) Herstellungsverfahren für einen Gegenstand
DE69808513T2 (de) Herstellungsverfahren für meta-xylol
DE69415603T2 (de) Herstellungsverfahren für Amylaseinhibitoren
DE69627800D1 (de) Herstellungsverfahren für halbleiteranordnung
DE69431454D1 (de) Amylase Inhibitoren
DE9413806U1 (de) Untersatz für Gläser
DE9319498U1 (de) Verbindungselement für plattenförmige Werkstücke
DE19681361T1 (de) Abstandshalter für Glasbausteine
DE9304045U1 (de) Bohrhilfe für Glasbrillen
DE69605658D1 (de) Herstellungsverfahren für Höcker
DE9409278U1 (de) Verkaufseinrichtung für Sets
NO900799D0 (no) Fremgangsmaate for fremstilling av inhibitorer for angiotensinomdannende enzym.
DE29507543U1 (de) Bausatz für Industriekoffer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NISSHIN PHARMA INC., TOKIO/TOKYO, JP NAGATA SANGYO

8339 Ceased/non-payment of the annual fee